摘要
Objective To observe the indication,Safety and efficacy of a new immunosuppressant Rituximab in kidney transplantation. Methods Five patients,who were diagnosed as antibody mediated rejection ( AMR) from December 2010 to June 2011,were treated with single dose of Rituximab ( 500 mg ) and followed up for
出处
《外科研究与新技术》
2011年第4期285-285,共1页
Surgical Research and New Technique
